14 results
10-K
2023 FY
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
condition and increase our costs and expenses.
Our operations could be subject to earthquakes, power shortages, telecommunications failures, water
424B4
NMRA
Neumora Therapeutics Inc.
18 Sep 23
Prospectus supplement with pricing info
4:12pm
operations could be subject to earthquakes, power shortages, telecommunications failures, water shortages, floods, hurricanes, typhoons, fires
S-1/A
EX-1.1
NMRA
Neumora Therapeutics Inc.
11 Sep 23
IPO registration (amended)
6:07am
Communication and (ii) it has not authorized anyone other than J.P. Morgan, BofAS, Stifel and Guggenheim to engage in Testing-the-Water Communications
S-1/A
NMRA
Neumora Therapeutics Inc.
11 Sep 23
IPO registration (amended)
6:07am
be subject to earthquakes, power shortages, telecommunications failures, water shortages, floods, hurricanes, typhoons, fires, extreme weather conditions
S-1
94mdz0xpg74
25 Aug 23
IPO registration
5:03pm
DRS/A
opnl4 waq
9 Aug 23
Draft registration statement (amended)
12:00am
DRS/A
60wxoxzx42sjx7m4s6y
30 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
8i8qozgxxi
2 May 23
Draft registration statement (amended)
12:00am
DRS/A
40fk4x
2 Sep 22
Draft registration statement (amended)
12:00am
DRS/A
nvnaf4dr2mkrrce
10 Jun 22
Draft registration statement (amended)
12:00am
DRS/A
03gf40v6q
2 May 22
Draft registration statement (amended)
12:00am
DRS/A
94w9akg xz
23 Dec 21
Draft registration statement (amended)
12:00am
DRS
3fmd4wbeo4n r7w
8 Nov 21
Draft registration statement
12:00am
- Prev
- 1
- Next